Nandinii Ramasenderan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nandinii Ramasenderan has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Ahmad Sukari Halim
Hospital Universiti Sains Malaysia, Kota Bharu, Malaysia
1 shared publication- Ahmad Sukari Halim
Hospital Universiti Sains Malaysia, Jalan Raja Perempuan Zainab II, Kubang Kerian, Kota Bharu, Kelantan, Malaysia
1 shared publication Hasliza Shahir
Department of Plastic and Reconstructive Surgery, Sultanah Nur Zahirah Hospital, Jalan Sultan Mahmud, 20400, Kuala Terengganu, Terengganu, Malaysia
1 shared publicationMohd Shakir Bathusha Mohd Hussain
Hospital Sultanah Nur Zahirah, Kuala Terengganu, Malaysia
1 shared publicationSiti Zarqah Omar
Department of Pathology, Sultanah Nur Zahirah Hospital, Jalan Sultan Mahmud, 20400, Kuala Terengganu, Terengganu, Malaysia
1 shared publication
Latest Publications
- Open Access
- 8 May 2022
- Published by Elsevier in Asian Journal of Surgery
- Vol. 46 (1) , 47-51
High-risk cutaneous squamous cell carcinoma (CSCC): Challenges and emerging therapies
- 8 May 2022
- Published by Elsevier in Asian Journal of Surgery
- Vol. 46 (1) , 47-51
Open AccessHigh-risk cutaneous squamous cell carcinoma (CSCC): Challenges and emerging therapies
- 17 May 2021
- Published by SAGE Publications in Asia Pacific Journal of Public Health
- Vol. 33 (5) , 657-659
Impact of COVID-19 on Plastic and Reconstructive Surgery Practice—Comparing Malaysia and Other Asian Countries: A Preliminary Study
- 17 May 2021
- Published by SAGE Publications in Asia Pacific Journal of Public Health
- Vol. 33 (5) , 657-659
Impact of COVID-19 on Plastic and Reconstructive Surgery Practice—Comparing Malaysia and Other Asian Countries: A Preliminary Study
- Open Access
- 1 January 2018
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 42 (C) , 116-120
A synchronous incidence of eccrine porocarcinoma of the forearm and facial squamous cell carcinoma
Introduction: Cutaneous appendageal tumor can differentiate towards or arise from either pilosebaceous apparatus or the eccrine sweat glands. Appendageal tumors are relatively rare, their clinical appearance is non-specific, and the vast majority are not diagnosed until after excision. Eccrine porocarcinoma (EP), also known as malignant eccrine poroma is a rare adnexal tumor arising from the intraepithelial ductal parts of the sweat gland. Case presentation: We presented a 65-year-old, Asian, female with medical co-morbids, who came with both a facial squamous cell carcinoma and a long-standing lesion over her left forearm. Histopathological finding of the left forearm demonstrated eccrine porocarcinoma. Conclusion: Mohs micrographic surgery is the mainstay treatment of cutaneous carcinoma. It is important to rule out associated syndromes in patient who present with multiple cutaneous appendageal tumors. Highlights:
- 1 January 2018
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 42 (C) , 116-120
Open AccessA synchronous incidence of eccrine porocarcinoma of the forearm and facial squamous cell carcinoma
Introduction: Cutaneous appendageal tumor can differentiate towards or arise from either pilosebaceous apparatus or the eccrine sweat glands. Appendageal tumors are relatively rare, their clinical appearance is non-specific, and the vast majority are not diagnosed until after excision. Eccrine porocarcinoma (EP), also known as malignant eccrine poroma is a rare adnexal tumor arising from the intraepithelial ductal parts of the sweat gland. Case presentation: We presented a 65-year-old, Asian, female with medical co-morbids, who came with both a facial squamous cell carcinoma and a long-standing lesion over her left forearm. Histopathological finding of the left forearm demonstrated eccrine porocarcinoma. Conclusion: Mohs micrographic surgery is the mainstay treatment of cutaneous carcinoma. It is important to rule out associated syndromes in patient who present with multiple cutaneous appendageal tumors. Highlights: